A combined proteomics and mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer
Aayah Nounu*, Alexander Greenhough, Kate J. Heesom, Rebecca C. Richmond, Jie Zheng, Stephanie J. Weinstein, Demetrius Albanes, John A. Baron, John L. Hopper, Jane C. Figueiredo, Polly A. Newcomb, Noralane M. Lindor, Graham Casey, Elizabeth A. Platz, Loc Le Marchand, Cornelia M. Ulrich, Christopher I. Li, Franzel J.B. van Duijnhoven, Andrea Gsur, Peter T. CampbellVíctor Moreno, Pavel Vodicka, Ludmila Vodickova, Hermann Brenner, Jenny Chang-Claude, Michael Hoffmeister, Lori C. Sakoda, Martha L. Slattery, Robert E. Schoen, Marc J. Gunter, Sergi Castellví-Bel, Hyeong Rok Kim, Sun Seog Kweon, Andrew T. Chan, Li Li, Wei Zheng, D.T. Bishop, Daniel D. Buchanan, Graham G. Giles, Stephen B. Gruber, Gad Rennert, Zsofia K. Stadler, Tabitha A. Harrison, Yi Lin, Temitope O. Keku, Michael O. Woods, Clemens Schafmayer, Bethany van Guelpen, Steven Gallinger, Heather Hampel, Sonja I. Berndt, Paul D.P. Pharoah, Annika Lindblom, Alicja Wolk, Anna H. Wu, Emily White, Ulrike Peters, David A. Drew, Dominique Scherer, Justo L. Bermejo, Ann C. Williams, Caroline L. Relton
Dive into the research topics of 'A combined proteomics and mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer'. Together they form a unique fingerprint.